Home Applications 210910 Application 210910
Type NDA
Sponsor REDHILL Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AEMCOLO RIFAMYCIN SODIUM TABLET, DELAYED RELEASE;ORAL EQ 194MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N210910-001 AEMCOLO RIFAMYCIN SODIUM EQ 194MG BASE TABLET, DELAYED RELEASE / ORAL RLD 2018-11-16
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N210910-001 NCE 2023-11-16 N210910-001 GAIN 2028-11-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N210910-001 AEMCOLO EQ 194MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2018-11-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N210910-001 AEMCOLO EQ 194MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2018-11-16 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N210910-001 AEMCOLO EQ 194MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2018-11-16 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N210910-001 AEMCOLO EQ 194MG BASE TABLET, DELAYED RELEASE / ORAL RLD 2018-11-16 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 156 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210910-001 8263120 2025-05-03 Drug product 2018-12-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210910-001 8486446 2025-05-03 Drug product 2018-12-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210910-001 8529945 2025-05-03 Drug product 2018-12-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210910-001 8741948 2025-05-03 U-2448 Drug product 2018-12-06 79d66fd596c7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 56 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 57841-1200 Aemcolo Rifamycin RedHill Biopharma Ltd NDA Current 57841-1200 Aemcolo Rifamycin RedHill Biopharma Ltd NDA Current 57841-1201 Aemcolo Rifamycin RedHill Biopharma Ltd NDA Current 57841-1201 Aemcolo Rifamycin RedHill Biopharma Ltd NDA Current 71068-001 Aemcolo Rifamycin Aries Pharmaceuticals Inc NDA Current 71068-001 Aemcolo Rifamycin Aries Pharmaceuticals Inc NDA Current 71068-001 Aemcolo Rifamycin Aries Pharmaceuticals Inc NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 59331 SUPPL 2019-07-15 56983 ORIG 2018-12-21 56517 ORIG 2018-11-20 56503 ORIG 2018-11-19